Oslo, Norway

Martin Mansson

This inventor holds 5 USPTO granted patents and 1 published patent application, plus 2 CIPO patents. Top assignee: Xellia Pharmaceuticals Aps. Active years: 2013-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Mansson. Retrieved from https://idiyas.com/inventor/martin-mansson-dbb8ro1k

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 80.0


Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Journey of Martin Mansson

Introduction

Martin Mansson, an esteemed inventor based in Oslo, Norway, has made significant contributions to the field of pharmaceuticals. With a portfolio boasting five patents, Mansson stands out as a thought leader and innovator in his industry. His inventive spirit is reflected in his latest advancements that address pressing needs in medicine.

Latest Patents

Mansson's recent patents highlight his commitment to advancing pharmaceutical technologies. One of his notable inventions is a composition comprising at least one polymyxin or a salt thereof, which details a unique formula designed to enhance therapeutic efficacy. This formulation includes aliphatic linear or branched C-C acyl groups, providing a novel approach to antibiotic development.

Additionally, Mansson has patented the use of 2-amino-3-methyl-hex-5-enoic acid in the production of peptides such as bacitracins. His work focuses on innovative methods for producing this compound, showcasing his depth of knowledge in peptide synthesis and its applications in medical treatments.

Career Highlights

Mansson's work primarily revolves around his role at Xellia Pharmaceuticals Aps, where he has played a pivotal role in advancing the company's research initiatives. His focus on patentable innovations has propelled the company’s standing in the pharmaceutical field, illustrating his dedication to pushing the boundaries of scientific inquiry.

Collaborations

Throughout his career, Martin has collaborated with several talented professionals, including Christine Senstad and Vidar Bjornstad. These partnerships have fostered a rich environment of shared knowledge and mutual support, further enhancing the innovative culture at Xellia Pharmaceuticals.

Conclusion

Martin Mansson’s contributions to the field of pharmaceuticals through his patents exemplify the importance of innovation in addressing current health challenges. With a robust portfolio and noteworthy collaborations, he continues to make strides in the industry, solidifying his reputation as a leading inventor. His work not only influences his company but also the broader sphere of medical science, proving that inventive minds can effect meaningful change.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…